Ποια είναι η τιμή για Genomic Vision S.A. (GV)

Η τιμή για Genomic Vision S.A. (GV) είναι $0.00196068

Ποια είναι η κεφαλαιοποίηση αγοράς για Genomic Vision S.A. (GV)

Η κεφαλαιοποίηση αγοράς για Genomic Vision S.A. (GV) είναι $16.64K

Genomic Vision S.A. (GV) Τιμή και Κεφαλαιοποίηση Αγοράς

Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.

Η τιμή για GV	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$634,318 $16.64K	NVDA	$5.383T	+32,352,000,318.50%
$521,206 $16.64K	AAPL	$4.423T	+26,582,945,946.58%
$490,214 $16.64K	GOOG	$4.160T	+25,002,282,125.49%
$431,647 $16.64K	MSFT	$3.663T	+22,015,203,999.28%
$340,672 $16.64K	AMZN	$2.891T	+17,375,216,229.83%

Η τιμή για GV

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$634,318 $16.64K